SCOTS-KNIGHT DENISE (Chief Executive Officer) sold 15.8% of their position (132.99K shares) of MEREO BIOPHARMA GROUP PLC on the open market
Open‑market sale worth $463.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/27/2024ACC: 0000950170-24-078465
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-132.99K
Net shares
Net seller
$463.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
132.99K disposed
Non-Derivative Transactions2
American Depositary Shares representing Ordinary Shares
Direct
Shares
−40.71K
Price / share
$3.69
Trade value
$150.39K
% of position
4.8%
6/25/2024
842.50K→801.79K
American Depositary Shares representing Ordinary Shares
Direct
Shares
−92.27K
Price / share
$3.39
Trade value
$313.10K
% of position
11.5%
6/26/2024
801.79K→709.52K
Total
Net shares
−132.99K
Net value
-$463.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 6/25/2024 | S · Sale | −40.71K | $3.69 | $150.39K | 4.8% | 842.50K | 801.79K |
| American Depositary Shares representing Ordinary Shares Direct | 6/26/2024 | S · Sale | −92.27K | $3.39 | $313.10K | 11.5% | 801.79K | 709.52K |
| Total | −132.99K | -$463.49K | ||||||
Derivative Transactions0
No derivative transactions reported